Strategic Advisors LLC Merck & Co., Inc. Transaction History

Strategic Advisors LLC

$530 Million
Q3 2024

A detailed history of Strategic Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Strategic Advisors LLC holds 13,312 shares of MRK stock, worth $1.31 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

13,312

Previous 13,244 0.51%

Holding current value

$1.31 Million

Previous $1.64 Million 7.81%

% of portfolio

0.29%

Previous 0.32%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$111.15 - $128.97 $7,558 - $8,769	68 Added 0.51%	13,312 $1.51 Million
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $49,520 - $53,184	-400 Reduced 2.93%	13,244 $1.64 Million
Q1 2024 Apr 19, 2024	SELL	$113.24 - $131.95 $181,070 - $210,988	-1,599 Reduced 10.49%	13,644 $1.8 Million
Q4 2023 Jan 19, 2024	BUY	$100.18 - $109.02 $8,415 - $9,157	84 Added 0.55%	15,243 $1.66 Million
Q3 2023 Oct 13, 2023	SELL	$102.95 - $114.33 $58,166 - $64,596	-565 Reduced 3.59%	15,159 $1.56 Million
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $5,864 - $6,392	-54 Reduced 0.34%	15,724 $1.81 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $76,896 - $85,800	-747 Reduced 4.52%	15,778 $1.68 Million
Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $6.37 Million - $8.16 Million	-72,804 Reduced 81.5%	16,525 $0
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $467,450 - $525,128	-5,530 Reduced 5.83%	89,329 $7.69 Million
Q2 2022 Aug 03, 2022	SELL	$83.49 - $94.64 $15,111 - $17,129	-181 Reduced 0.19%	94,859 $8.65 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $38,225 - $42,848	-520 Reduced 0.54%	95,040 $7.8 Million
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $3.9 Million - $4.88 Million	53,929 Added 129.54%	95,560 $7.32 Million
Q3 2021 Oct 21, 2021	BUY	$71.68 - $78.83 $1.48 Million - $1.62 Million	20,593 Added 97.88%	41,631 $3.13 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $60,747 - $67,193	-864 Reduced 3.94%	21,038 $1.64 Million
Q1 2021 May 05, 2021	BUY	$68.86 - $81.11 $206 - $243	3 Added 0.01%	21,902 $1.69 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $1,722 - $1,911	-24 Reduced 0.11%	21,899 $1.84 Million
Q3 2020 Oct 13, 2020	SELL	$73.18 - $82.95 $7,025 - $7,963	-96 Reduced 0.44%	21,923 $1.78 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $704 - $801	10 Added 0.05%	22,019 $1.73 Million
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $20,401 - $28,278	322 Added 1.48%	22,009 $1.8 Million
Q4 2019 Feb 05, 2020	BUY	$77.58 - $87.54 $26,765 - $30,201	345 Added 1.62%	21,687 $1.97 Million
Q3 2019 Oct 17, 2019	BUY	$76.08 - $82.93 $32,410 - $35,328	426 Added 2.04%	21,342 $1.8 Million
Q2 2019 Jul 22, 2019	SELL	$69.84 - $81.59 $21,650 - $25,292	-310 Reduced 1.46%	20,916 $1.75 Million
Q1 2019 Apr 15, 2019	SELL	$69.58 - $79.36 $1.2 Million - $1.37 Million	-17,241 Reduced 44.82%	21,226 $1.77 Million
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $58,585 - $67,987	-898 Reduced 2.28%	38,467 $2.94 Million
Q3 2018 Oct 18, 2018	SELL	$57.69 - $67.84 $15,460 - $18,181	-268 Reduced 0.68%	39,365 $2.79 Million
Q2 2018 Jul 30, 2018	SELL	$50.83 - $59.72 $93,069 - $109,347	-1,831 Reduced 4.42%	39,633 $2.41 Million
Q1 2018 Apr 19, 2018	SELL	$50.96 - $59.23 $80,924 - $94,057	-1,588 Reduced 3.69%	41,464 $2.26 Million
Q4 2017 Jan 16, 2018	BUY	$51.62 - $61.64 $114,596 - $136,840	2,220 Added 5.44%	43,052 $2.42 Million
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $68,115 - $73,293	-1,161 Reduced 2.76%	40,832 $2.61 Million
Q2 2017 Aug 10, 2017	BUY	N/A	41,993	41,993 $2.69 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.

Account

Strategic Advisors LLC Merck & Co., Inc. Transaction History